Key facts
- This page summarizes Daniel Lynch's Form 4 filing for 2seventy bio, Inc. (TSVT).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 09 Jun 2022, 18:20.
Daniel Lynch - 08 Jun 2022 Form 4 Insider Report for 2seventy bio, Inc. (TSVT)
- Reporting relationship
- Director
- Issuer ticker
- TSVT
- Reported as of
- 08 Jun 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Jun 2022, 18:20:19 UTC
- Prior SEC filing
- 20 May 2022
- Next SEC filing
- 25 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Teresa Jurgensen, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Daniel Lynch filed Form 4 for 2seventy bio, Inc. (TSVT) on 09 Jun 2022.
Change
- Previous filing in this sequence was filed on 20 May 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TSVT
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +7,200
- Change %
- +132%
- Price
- $0.000000
- Shares after
- 12,653
- Date
- 08 Jun 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TSVT
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +14,400
- Change %
- Price
- $0.000000
- Shares after
- 14,400
- Date
- 08 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 14,400
- Exercise price
- $13.51
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These restricted stock units vest 100% on the earlier of June 8, 2023 or the date of the next annual meeting of stockholder of 2seventy bio, Inc.
Footnote F2
This option vests 100% on the earlier of June 8, 2023 or the date of the next annual meeting of stockholders of 2seventy bio, Inc.